Building value across biopharma and medical devices.
Fortis BioPharma acquires and advises in the biopharmaceutical and medical device space — across established regulatory pathways and the emerging frontiers of cell therapy, peptides, psychedelics and nutraceuticals.
Two ways we create value
We bring capital, operating experience and regulatory know-how to assets and companies with real potential — and we share that perspective with the teams building them.
Acquisitions
Assets, products and companies across biopharma and medical devices, backed by the work to move them forward.
Advisory
Strategy, positioning and the path to market for founders, investors and operators.
Proven pathways.
New frontiers.
Traditional regulatory pathways remain a core part of our business. We're equally committed to non-traditional opportunities, where science, demand and regulation are moving quickly.
Traditional regulatory pathways
Pharmaceuticals, biologics and medical devices moving through established development, clearance and approval routes, with the rigor those routes require.
Cell therapy
Living-cell medicines, and the manufacturing, logistics and regulatory strategy they demand.
Peptides
Peptide-based therapeutics, and the formulation, sourcing and pathway questions that come with them.
Psychedelics
Psychedelic-derived and psychedelic-inspired medicines, pursued within applicable research and regulatory frameworks.
Nutraceuticals
Nutraceutical and dietary supplement opportunities, from formulation and quality through to market.
Disciplined where it matters. Creative where it counts.
Identify
We look for assets and teams with strong science and a credible route to patients and customers, conventional or not.
Evaluate
We pressure-test the opportunity on its evidence, its regulatory path, its market and the people behind it.
Advance
Whether we acquire or advise, we stay hands-on to help move the work from where it is to where it needs to be.
Let's talk about what you're building.
Whether you have an asset to discuss, a company to position or a pathway to plan, we'd like to hear from you.